Shortwave Life Sciences Plc (@shortwaveplc) 's Twitter Profile
Shortwave Life Sciences Plc

@shortwaveplc

Biopharmaceutical company developing novel drug combinations & delivery method to treat patients from mental health disorders. Listed on AQSE: #PSY

ID: 1947620236582064128

calendar_today22-07-2025 11:30:34

11 Tweet

15 Followers

7 Following

ShareTalkNews™ (@sharetalknews) 's Twitter Profile Photo

StockBox🎙️📈📽️ spoke to Shortwave Life Sciences Plc co-founder Stephen Murphy & executive chairman Rolf Gerritsen following the #PYS’s £250,000 fundraise at a 150% premium to the market. Launching a digital asset management strategy They discussed the company’s strategic expansion into digital

Shortwave Life Sciences Plc (@shortwaveplc) 's Twitter Profile Photo

✅Raised £250,000 at a 150% premium to the market ✅Launching a digital asset management strategy ✅Strengthened leadership team with key appointments Learn more StockBox🎙️📈📽️: youtube.com/watch?v=M0nP_C… #PSY #StockBox

StockBox🎙️📈📽️ (@stockboxmedia) 's Twitter Profile Photo

We recently spoke to Shortwave Life Sciences Plc Co-Founder Stephen Murphy and Executive Chairman Rolf Gerritsen following the company’s £250,000 fundraise. Catch up on the full interview here: youtube.com/watch?v=M0nP_C… Learn more & follow along below⬇️ #PSY #StockBox

Shortwave Life Sciences Plc (@shortwaveplc) 's Twitter Profile Photo

TR-1 Notification of Major Holdings Shortwave Life Sciences Plc announces that Thomas Grant Nominees Limited has increased its holding to 4.71% (26,800,469 shares). 🔗 shortwavelifesciences.com/investor-centr… #PSY

TR-1 Notification of Major Holdings

Shortwave Life Sciences Plc announces that Thomas Grant Nominees Limited has increased its holding to 4.71% (26,800,469 shares). 

🔗  shortwavelifesciences.com/investor-centr…

#PSY
Shortwave Life Sciences Plc (@shortwaveplc) 's Twitter Profile Photo

Our Focus on Drug Delivery: 👩‍🔬Shortwave is a leader in developing delivery and administration methods for novel drug combinations, targeting unmet critical needs in mental health care. Learn more: shortwavelifesciences.com/shortwave-life… #PSY #MentalHealth

Our Focus on Drug Delivery:

👩‍🔬Shortwave is a leader in developing delivery and administration methods for novel drug combinations, targeting unmet critical needs in mental health care. 

Learn more: shortwavelifesciences.com/shortwave-life… 

#PSY #MentalHealth
StockBox🎙️📈📽️ (@stockboxmedia) 's Twitter Profile Photo

We recently spoke to Shortwave Life Sciences Plc co-founder Stephen Murphy and Executive Chairman Rolf Gerritsen. They cover: ✅Raised £250,000 at a 150% premium to the market ✅Launching a digital asset management strategy ✅Strengthened leadership team with key appointments Watch the

Shortwave Life Sciences Plc (@shortwaveplc) 's Twitter Profile Photo

Buccal Film Drug Delivery Platform: Shortwave’s mucoadhesive buccal film for the administration of its psilocybin-based combination drug product had completed its 2-year development in 2023, having currently stability of 9 months. #PSY #MentalHealth

Buccal Film Drug Delivery Platform:  

Shortwave’s mucoadhesive buccal film for the administration of its psilocybin-based combination drug product had completed its 2-year development in 2023, having currently stability of 9 months.   

#PSY #MentalHealth
Shortwave Life Sciences Plc (@shortwaveplc) 's Twitter Profile Photo

Anorexia nervosa is not just an eating disorder; it’s a life-threatening condition with devastating impact on individuals and families worldwide. At Shortwave, we’re committed to driving innovation in areas where solutions are most needed. 🔗 shortwavelifesciences.com #PSY

Anorexia nervosa is not just an eating disorder; it’s a life-threatening condition with devastating impact on individuals and families worldwide.

At Shortwave, we’re committed to driving innovation in areas where solutions are most needed.

🔗 shortwavelifesciences.com

 #PSY
Shortwave Life Sciences Plc (@shortwaveplc) 's Twitter Profile Photo

Despite the severity of anorexia nervosa, there are currently no FDA-approved pharmacological treatments. The gap is clear. The need is urgent. Shortwave is building solutions where none exist. 🔗 shortwavelifesciences.com #MentalHealth #PSY

Despite the severity of anorexia nervosa, there are currently no FDA-approved pharmacological treatments.

The gap is clear. The need is urgent. Shortwave is building solutions where none exist.

🔗 shortwavelifesciences.com

 #MentalHealth #PSY
Shortwave Life Sciences Plc (@shortwaveplc) 's Twitter Profile Photo

The economic burden of eating disorders is staggering: in 2020, the cost to the UK alone was estimated at $9.4 billion+. The human cost is even greater. Shortwave is working to change this story. 🔗 shortwavelifesciences.com #MentalHealth #PSY

The economic burden of eating disorders is staggering: in 2020, the cost to the UK alone was estimated at $9.4 billion+.

The human cost is even greater.

Shortwave is working to change this story.

🔗 shortwavelifesciences.com 

 #MentalHealth #PSY
Shortwave Life Sciences Plc (@shortwaveplc) 's Twitter Profile Photo

Anorexia nervosa: ❌ No approved medical treatment ❌ Billions in annual economic cost ✅ Huge unmet need Shortwave Life Sciences is moving fast to change the outlook for mental health treatment. Stay tuned. 🔗 shortwavelifesciences.com #PSY #MentalHealth

Anorexia nervosa:

 ❌ No approved medical treatment
 ❌ Billions in annual economic cost
 ✅ Huge unmet need

Shortwave Life Sciences is moving fast to change the outlook for mental health treatment.

Stay tuned.

🔗 shortwavelifesciences.com

 #PSY #MentalHealth
Shortwave Life Sciences Plc (@shortwaveplc) 's Twitter Profile Photo

🔔 Shortwave is pleased to announce the completion of its business review and outlines its plans to strengthen and grow the Company’s core operating business with an integrated supportive digital asset treasury management strategy. Read more: aquis.eu/stock-exchange… #PSY

🔔 Shortwave is pleased to announce the completion of its business review and outlines its plans to strengthen and grow the Company’s core operating business with an integrated supportive digital asset treasury management strategy.

Read more: aquis.eu/stock-exchange… 

#PSY
Shortwave Life Sciences Plc (@shortwaveplc) 's Twitter Profile Photo

Following the strategic review, Rolf Gerritsen comments: “A very exciting road lies ahead for Shortwave and we as a Board look forward to supplying regular updates on our progress, and making our impact felt.” Details in the RNS: aquis.eu/stock-exchange… #PSY

Following the strategic review, Rolf Gerritsen comments:

“A very exciting road lies ahead for Shortwave and we as a Board look forward to supplying regular updates on our progress, and making our impact felt.”

Details in the RNS: aquis.eu/stock-exchange…

#PSY
Shortwave Life Sciences Plc (@shortwaveplc) 's Twitter Profile Photo

Direction, Director Changes & Medical Adviser "The outcome of the business review is a clear pathway towards developing our core business, supported by a strong, united and highly qualified team..." Rolf Gerritsen commented. Catch up on the news: aquis.eu/stock-exchange… #PSY

Direction, Director Changes & Medical Adviser

"The outcome of the business review is a clear pathway towards developing our core business, supported by a strong, united and highly qualified team..." Rolf Gerritsen commented. 

Catch up on the news: aquis.eu/stock-exchange… 

#PSY
StockBox🎙️📈📽️ (@stockboxmedia) 's Twitter Profile Photo

Shortwave Life Sciences: Real Assets, Digital & Healthcare Innovation StockBox🎙️📈📽️ spoke to Exec. Chairman Rolf Gerritsen and Exec. Director Stephen Malloy from Shortwave Life Sciences Plc to discuss the company’s new direction following a business review. Watch below ⬇

Shortwave Life Sciences: Real Assets, Digital & Healthcare Innovation

<a href="/StockBoxMedia/">StockBox🎙️📈📽️</a> spoke to Exec. Chairman Rolf Gerritsen and Exec. Director Stephen Malloy from <a href="/ShortwavePLC/">Shortwave Life Sciences Plc</a> to discuss the company’s new direction following a business review.

 Watch below ⬇
Shortwave Life Sciences Plc (@shortwaveplc) 's Twitter Profile Photo

Exec. Chairman Rolf Gerritsen & Exec. Director Stephen Malloy Shortwave Life Sciences Plc join StockBox🎙️📈📽️ to discuss: ✅ Clinical trials moving ahead (Psilocybin) ✅ Digital asset treasury strategy ✅ Financial resilience & partnerships Watch here⬇ youtu.be/pKFGatpxHUY?si… #PSY

Exec. Chairman Rolf Gerritsen &amp; Exec. Director Stephen Malloy <a href="/ShortwavePLC/">Shortwave Life Sciences Plc</a> join <a href="/StockBoxMedia/">StockBox🎙️📈📽️</a> to discuss:

✅ Clinical trials moving ahead (Psilocybin) 
✅ Digital asset treasury strategy 
✅ Financial resilience &amp; partnerships 

 Watch here⬇
youtu.be/pKFGatpxHUY?si…

#PSY